{"name": "Jennerex Biotherapeutics",
 "permalink": "jennerex-biotherapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/jennerex-biotherapeutics",
 "homepage_url": "http://www.jennerex.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@jennerex.com",
 "phone_number": "415-281-8886",
 "description": "Cancer Research",
 "created_at": "Tue Sep 22 07:03:10 UTC 2009",
 "updated_at": "Fri May 24 04:39:55 UTC 2013",
 "overview": "\u003Cp\u003EJennerex is a clinical-stage biopharmaceutical company focused on the development and commercialization of first-in-class, breakthrough targeted oncolytic products for cancer. The company\u00e2\u20ac\u2122s lead product JX-594, currently in an international Phase 2 trial for primary liver cancer and colorectal cancer, demonstrated promising Phase 1 efficacy and safety results in patients with a diverse array of common cancers. \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       51],
      "assets/images/resized/0006/0426/60426v2-max-150x150.jpg"],
     [[197,
       67],
      "assets/images/resized/0006/0426/60426v2-max-250x250.jpg"],
     [[197,
       67],
      "assets/images/resized/0006/0426/60426v2-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President and CEO",
    "person":
     {"first_name": "Laurent",
      "last_name": "Fischer",
      "permalink": "laurent-fischer",
      "image": null}},
   {"is_past": false,
    "title": "COO",
    "person":
     {"first_name": "Lara",
      "last_name": "Longpre",
      "permalink": "lara-longpre",
      "image": null}},
   {"is_past": false,
    "title": "Board of Directors",
    "person":
     {"first_name": "Ken",
      "last_name": "Newport",
      "permalink": "ken-newport",
      "image": null}},
   {"is_past": false,
    "title": "Board of directors",
    "person":
     {"first_name": "Mitchell",
      "last_name": "H. Gold",
      "permalink": "mitchell-h-gold",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$44.3M",
 "funding_rounds":
  [{"round_code": "c",
    "source_url": "http://www.jennerex.com/pr-091809.html",
    "source_description": "Jennerex Completes Over-Subscribed Series C Financing for Aggregate Gross Proceeds of Over $5.5 Million ",
    "raised_amount": 5500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 9,
    "funded_day": 18,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Ottawa Regional Cancer Foundation",
         "permalink": "ottawa-regional-cancer-foundation",
         "image":
          {"available_sizes":
            [[[150,
               51],
              "assets/images/resized/0006/0428/60428v2-max-150x150.png"],
             [[250,
               85],
              "assets/images/resized/0006/0428/60428v2-max-250x250.png"],
             [[299,
               102],
              "assets/images/resized/0006/0428/60428v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "d",
    "source_url": "http://onbiovc.com/jennerex-biotherapeutics-inc-series-d-86m/",
    "source_description": "Jennerex Biotherapeutics, Inc.: Series D $8.6M",
    "raised_amount": 8600000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 10,
    "funded_day": 24,
    "investments":
     []},
   {"round_code": "unattributed",
    "source_url": "http://www.finsmes.com/2011/08/jennerex-completes-8-6m-financing.html?utm_source=feedburner\u0026utm_medium=feed\u0026utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29",
    "source_description": "Jennerex Completes $8.6M Financing",
    "raised_amount": 8600000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 8,
    "funded_day": 11,
    "investments":
     []},
   {"round_code": "private_equity",
    "source_url": "http://pevc.dowjones.com/article?an=DJFVW00020130523e95ns1wx0\u0026from=alert\u0026pid=32\u0026ReturnUrl=http%3a%2f%2fpevc.dowjones.com%3a80%2farticle%3fan%3dDJFVW00020130523e95ns1wx0%26from%3dalert%26pid%3d32",
    "source_description": "Jennerex Biotherapeutics Raises $21.6M for Cancer Therapy",
    "raised_amount": 21600000.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 5,
    "funded_day": 23,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "201 Mission Street",
    "address2": "Suite 1380",
    "zip_code": "94105",
    "city": "San Francisco",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "Transgene teams with Jennerex in $116M cancer pact",
    "stoned_year": 2010,
    "stoned_month": 9,
    "stoned_day": 8,
    "source_url": "http://www.fiercebiotech.com/story/transgene-teams-jennerex-116m-cancer-pact/2010-09-08?utm_medium=rss\u0026utm_source=rss",
    "source_text": "",
    "source_description": "Transgene teams with Jennerex in $116M cancer pact",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Jennerex Biotherapeutics",
      "permalink": "jennerex-biotherapeutics"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        104],
       "assets/images/resized/0006/0427/60427v1-max-150x150.jpg"],
      [[250,
        173],
       "assets/images/resized/0006/0427/60427v1-max-250x250.jpg"],
      [[450,
        312],
       "assets/images/resized/0006/0427/60427v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}